Literature DB >> 35199573

Immunofluorescence Detection of Plasma Membranous PTEN in Cultured Cells.

Takashi Kato1,2.   

Abstract

PTEN is a well-known tumor suppressor with various functions that depend on its intracellular localization. Green fluorescent protein (GFP)-tagged live-cell images clarified the crucial amino acids needed to regulate the localization of PTEN in cells. However, it currently remains unknown whether GFP itself affects the intracellular localization of PTEN and its mutants, and the establishment of fixed-cell imaging is important for identifying the exact location of PTEN in cells. I herein investigated a number of immunofluorescence strategies for cell fixation, membrane permeabilization, and antigen retrieval. Permeabilization by detergents was necessary to observe nuclear and cytosolic PTEN in paraformaldehyde (PFA)-fixed cells; however, this permeabilization was not always valid. On the other hand, antigen retrieval by the pre-boiled EDTA treatment was useful for detecting plasma membranous PTEN in PFA-fixed cells in the same manner as in in vivo studies. Furthermore, methanol-fixed images of PTEN were consistent with GFP-tagged live-cell images. Two immunofluorescence methods (the PFA-fixed/pre-boiled EDTA treatment and methanol fixation) are applicable to investigations of the intracellular localization of PTEN without a GFP tag in cultured cells. In conclusion, live-cell imaging and appropriate immunofluorescence including a novel antigen retrieval treatment were both useful for detecting the cellular localization of PTEN, particularly at the plasma membrane.

Entities:  

Keywords:  PTEN; immunofluorescence; nucleus; plasma membrane

Mesh:

Substances:

Year:  2022        PMID: 35199573      PMCID: PMC8971685          DOI: 10.1369/00221554221082539

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  24 in total

1.  The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.

Authors:  Y Lu; Y Z Lin; R LaPushin; B Cuevas; X Fang; S X Yu; M A Davies; H Khan; T Furui; M Mao; R Zinner; M C Hung; P Steck; K Siminovitch; G B Mills
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

2.  Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.

Authors:  Michele I Vitolo; Michele B Weiss; Marta Szmacinski; Khola Tahir; Todd Waldman; Ben Ho Park; Stuart S Martin; David J Weber; Kurtis E Bachman
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

3.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

4.  Antigen retrieval techniques in immunohistochemistry: comparison of different methods.

Authors:  S A Pileri; G Roncador; C Ceccarelli; M Piccioli; A Briskomatis; E Sabattini; S Ascani; D Santini; P P Piccaluga; O Leone; S Damiani; C Ercolessi; F Sandri; F Pieri; L Leoncini; B Falini
Journal:  J Pathol       Date:  1997-09       Impact factor: 7.996

5.  Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN.

Authors:  M A Davies; D Koul; H Dhesi; R Berman; T J McDonnell; D McConkey; W K Yung; P A Steck
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

6.  Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities.

Authors:  Hoai-Nghia Nguyen; Jr-Ming Yang; Yashar Afkari; Ben Ho Park; Hiromi Sesaki; Peter N Devreotes; Miho Iijima
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

7.  Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms.

Authors:  Takashi Kato; Daisuke Murata; Robert A Anders; Hiromi Sesaki; Miho Iijima
Journal:  Biochem Biophys Res Commun       Date:  2021-03-02       Impact factor: 3.575

8.  Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.

Authors:  Jr-M Yang; P Schiapparelli; H-N Nguyen; A Igarashi; Q Zhang; S Abbadi; L M Amzel; H Sesaki; A Quiñones-Hinojosa; M Iijima
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 9.  PTEN: Tumor Suppressor and Metabolic Regulator.

Authors:  Chien-Yu Chen; Jingyu Chen; Lina He; Bangyan L Stiles
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.